TERT-BUTYL 4-BENZYL-3-OXO-1-OXA-4,9-DIAZASPIRO[5.5]UNDECANE-9-CARBOXYLATE
95%
- Product Code: 75921
CAS:
1352925-95-1
| Molecular Weight: | 360 g./mol | Molecular Formula: | C₂₀H₂₈N₂O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD21099576 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as an intermediate in the synthesis of various biologically active molecules. Its spirocyclic structure makes it a valuable building block for developing compounds with potential therapeutic applications, particularly in the design of drugs targeting neurological disorders. The presence of the oxa and diaza groups within the spirocyclic framework allows for interactions with biological targets, such as enzymes or receptors, making it a key component in the creation of novel pharmaceutical agents. Additionally, its stability and structural complexity contribute to its use in the exploration of new chemical entities for drug discovery programs.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | ฿8,200.00 |
+
-
|
| 0.250 | 10-20 days | ฿19,110.00 |
+
-
|
| 1.000 | 10-20 days | ฿39,340.00 |
+
-
|
TERT-BUTYL 4-BENZYL-3-OXO-1-OXA-4,9-DIAZASPIRO[5.5]UNDECANE-9-CARBOXYLATE
This compound is primarily utilized in the field of medicinal chemistry as an intermediate in the synthesis of various biologically active molecules. Its spirocyclic structure makes it a valuable building block for developing compounds with potential therapeutic applications, particularly in the design of drugs targeting neurological disorders. The presence of the oxa and diaza groups within the spirocyclic framework allows for interactions with biological targets, such as enzymes or receptors, making it a key component in the creation of novel pharmaceutical agents. Additionally, its stability and structural complexity contribute to its use in the exploration of new chemical entities for drug discovery programs.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :